Key terms
About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ABT news
Nov 20
4:57am ET
Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Nov 19
12:45pm ET
Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules
Nov 17
9:36am ET
Wells Fargo Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Nov 05
5:35am ET
Abbott price target raised to $149 from $143 at Barclays
Nov 04
7:26am ET
Abbott price target raised to $149 from $143 at Barclays
Nov 04
6:46am ET
Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating
Nov 01
9:48am ET
Reckitt and Abbott Shares Rally on Baby Formula Lawsuit Win
Nov 01
8:55am ET
Morning Movers: Apple dips, Amazon gains after earnings
Nov 01
8:12am ET
Oppenheimer Sticks to Their Buy Rating for Abbott Laboratories (ABT)
Nov 01
7:55am ET
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
Nov 01
6:29am ET
Abbott Laboratories (ABT) Gets a Buy from Piper Sandler
Nov 01
5:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT) and Merck & Company (MRK)
Oct 30
10:20pm ET
Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Abbott Laboratories (ABT)
Oct 30
10:20pm ET
Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT)
Oct 30
7:45am ET
Abbott Laboratories (ABT) Gets a Buy from TD Cowen
Oct 28
2:25pm ET
Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott
Oct 24
9:10am ET
Abbott initiates clinical trial of its CardioMems in advanced heart failure
Oct 17
8:36am ET
Abbott price target raised to $130 from $115 at Mizuho
Oct 17
8:08am ET
Citi Keeps Their Buy Rating on Abbott Laboratories (ABT)
Oct 17
8:05am ET
Oppenheimer Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Oct 17
7:30am ET
Abbott price target raised to $146 from $143 at UBS
Oct 17
7:12am ET
Abbott price target raised to $133 from $131 at Piper Sandler
Oct 17
6:48am ET
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Oct 17
6:48am ET
Abbott Laboratories (ABT) Gets a Buy from Piper Sandler
Oct 17
6:46am ET
RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)
Oct 17
6:41am ET
Abbott price target raised to $138 from $133 at Bernstein
Oct 17
6:32am ET
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Oct 17
6:31am ET
Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential
Oct 17
6:29am ET
Abbott Laboratories: Strong Buy Rating Driven by Robust Growth Prospects and Operational Improvements
Oct 17
5:36am ET
Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook
Oct 16
4:35pm ET
Abbott Laboratories: Balanced Prospects Lead to Hold Recommendation Amid Market Adjustments
Nov 22
11:30am ET
Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report?
Nov 22
10:15am ET
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Nov 20
9:00am ET
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Nov 19
9:30am ET
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
Nov 13
10:28am ET
Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next?
Nov 08
8:13am ET
The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE
Nov 07
4:20pm ET
Top Stock Reports for Amazon.com, Procter & Gamble & Abbott
Nov 07
11:40am ET
PAHC or ABT: Which Is the Better Value Stock Right Now?
Nov 07
11:10am ET
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?
Nov 05
9:00am ET
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Oct 31
6:20am ET
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Oct 29
10:43am ET
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?
Oct 29
10:28am ET
Here's Why You Should Retain ABT Stock in Your Portfolio Now
Oct 29
8:07am ET
ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock
Oct 25
12:25pm ET
HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View
Oct 24
1:37pm ET
Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums
Oct 24
1:29pm ET
Community Health Q3 Earnings Miss on Lower Adjusted Admissions
Oct 23
12:20pm ET
Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt
Oct 23
9:00am ET
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Oct 21
4:52pm ET
Top Research Reports for Visa, Netflix & Merck
Oct 21
11:40am ET
MDT vs. ABT: Which Stock Is the Better Value Option?
ABT Financials
Key terms
Ad Feedback
ABT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ABT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
